In this section

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B

Dahlof, B. et al. (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B. Lancet, 366, pp. 895-906. (doi: 10.1016/S0140-6736(05)67185-1)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Gordon
Authors: Dahlof, B., Sever, P., Poulter, N., Wedel, H., Beevers, D., Caulfield, M., Collins, R., Kjeldsen, S., Kristinsson, A., McInnes, G., Mehlsen, J., Nieminen, M., OBrien, E., Ostergren, J., and ASCOT Investigators,
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Lancet
Publisher:The Lancet Publishing Group
ISSN:0140-6736
ISSN (Online):1474-547X

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details